PETNET Solutions

Delivering PET Biomarkers

PETNET Solutions has carefully planned and successfully built the SafetyNet™, a unique program by which your delivery of PET tracers is guaranteed on time through our national network of cyclotron-based radiopharmacies.

On time and reliable delivery of high quality PET biomarkers is essential for the successful operation of a PET practice. The SafetyNet guarantees dose delivery of molecular biomarkers to hospitals, clinics, and research facilities.

Biomarker manufacturing, delivery and other services are local and each of PETNET Solutions' cyclotron-equipped radiopharmacies are backed by SafetyNet, so on time delivery to you and your patient is guaranteed.

PETNET Solutions can deliver FDG to 99% of all hospitals and imaging centers in the United States.

Case Studies:

[¹⁸F]FDG

47 year old female, 51.8 kg (114 lbs) - 3 weeks post sigmoid adenomacarcinoma resection for staging PET and CT reveal multiple hepatic mestastasis and left pelvic osseous metastasis.

Data courtesy of PET Medical Imaging Center, Grand Rapids, MI, Dr. Paul Shreve Director

Na[¹⁸F]

Abnormal uptake consistent with metastatic disease in the vertebral bodies L3, L5, superior end plate of L4 and right transverse process of L3, consistent with metastatic disease. Innumerable lesions are identified in the pelvis that are only appreciated in retrospect on CT. Focal uptake in the left 7th rib and right glenoid consistent with metastatic disease. Additional focus of activity seen in the proximal metaphysis of the right femur that is visualized, if at all, on the SPECT bone scan.

Patient received appropriate treatment with the systemic therapy after accurate identification of the presence and extent of bone disease.

Data courtesy of Seattle Nuclear Medicine, Seattle, WA, David Haseley, MD